phase readout
saveNCT07568041: Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Cenna Biosciences Inc.. Phase: PHASE1. Conditions: Alzheimer's Disease (AD)
view source ↗
comments(0)
5-min edit window · permanent after that